Corporate News

Bates News
For 20 years, “Therapeutic Topics” has explored ocular disease. Here’s an update on where translational medicine stands today.
Dry Eye Syndrome, results expected in Q3/2015
A drug-eluting punctum plug, that is being evaluated by Ocular Therapeutix
Continuing to show positive results in Phase 3 will be an important breakthrough for treating NK
The acquisition of Aciex represents a significant step forward in Nicox's strategy of creating an international ophthalmic company
A look at the mechanism behind neurotrophic keratitis as well as current and future methods for treating it.
French drug developer NiCox S.A. last week announced plans to buy Aciex Therapeutics

Pages

Subscribe to Corporate News